Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01324609 · ClinicalTrials.gov registry record
Detection of Choroidal Nevus Cells in Vitrectomy Fluid
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 2
- Enrollment target
NCT01324609: Clinical Trial study, sponsored by Stanford University.
NCT01324609 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01324609 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the investigators can detect the presence of choroidal nevi cells in the vitreous fluid of humans, as this may improve the diagnosis and classification of choroidal nevi and melanomas in the future.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2010-06 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01324609
The ClinicalTrials.gov registry entry for NCT01324609 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01324609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01324609 about?
NCT01324609 is a clinical study titled "Detection of Choroidal Nevus Cells in Vitrectomy Fluid". The purpose of this study is to determine if the investigators can detect the presence of choroidal nevi cells in the vitreous fluid of humans, as this may improve the diagnosis and classification of choroidal nevi and melanomas in the future.
What is the current status of trial NCT01324609?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2010-06. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT01324609?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.